Submitted by medicalnewstoday7131 in health
A phase 2 clinical trial conducted by industry developers suggests that Bryostatin-1 may be safe and promising in the treatment of advanced Alzheiemer's disease
Submitted by medicalnewstoday7131 in health
A phase 2 clinical trial conducted by industry developers suggests that Bryostatin-1 may be safe and promising in the treatment of advanced Alzheiemer's disease